Bone Morphogenetic Protein Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

Bone Morphogenetic Protein Market is Segmented by Type (Recombinant Human Bone Morphogenetic (rhBMP)- 2 and Recombinant Human Bon Morphogenetic Protein (rhBMP) - 7), Application (Spinal Fusion, Trauma, Reconstructive Surgery, Oral-maxillofacial), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The market provides the value (in USD million) for the above-mentioned segments.

Bone Morphogenetic Protein Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

Bone Morphogenetic Protein Industry Overview

The Bone Morphogenetic Protein Market is moderately competitive and consists of several companies. In terms of market share, a small number of major players currently dominate the market. However, with technological advancement and product innovation, mid-size to smaller companies are increasing their market presence by introducing new products at affordable prices. Companies like Medtronic Inc., Stryker Corporation, and Thermo Fischer Scientific hold a substantial market share.

Bone Morphogenetic Protein Market Leaders

  1. Medtronic plc.

  2. Stryker Corporation

  3. Thermo Fischer Scientific

  4. Merck KGaA

  5. Johnson & Johnson

  6. *Disclaimer: Major Players sorted in no particular order
Bone Morphogenetic Protein Market Concentration